A Novel Peptide, HS1002, Enhances Antitumor Activity via Dual Targeting of the GnRH Receptor and Human Telomerase Reverse Transcriptase in Prostate Cancer Cells.
Saved in:
| Title: | A Novel Peptide, HS1002, Enhances Antitumor Activity via Dual Targeting of the GnRH Receptor and Human Telomerase Reverse Transcriptase in Prostate Cancer Cells. |
|---|---|
| Authors: | Park JH; School of Pharmacy Sungkyunkwan University Suwon Republic of Korea., Lee JC; School of Pharmacy Sungkyunkwan University Suwon Republic of Korea., Sharma S; School of Pharmacy Sungkyunkwan University Suwon Republic of Korea., Jiang C; School of Pharmacy Sungkyunkwan University Suwon Republic of Korea., Lee H; School of Pharmacy Sungkyunkwan University Suwon Republic of Korea., Park HJ; School of Pharmacy Sungkyunkwan University Suwon Republic of Korea., Kim HS; School of Pharmacy Sungkyunkwan University Suwon Republic of Korea. |
| Source: | MedComm [MedComm (2020)] 2026 Feb 15; Vol. 7 (3), pp. e70630. Date of Electronic Publication: 2026 Feb 15 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: China NLM ID: 101769925 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-2663 (Electronic) Linking ISSN: 26882663 NLM ISO Abbreviation: MedComm (2020) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2688-2663 |
|---|---|
| DOI: | 10.1002/mco2.70630 |
